You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PSMA-I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

Not yet recruiting
  • Prostate Cancer
  • [177Lu]Lu-PSMA I&T
  • Stereotactic Radiotherapy
  • (no location specified)
May 30, 2023

Metastasis From Malignant Tumor of Prostate (Disorder) Trial in United States (64Cu-PSMA I&T)

Recruiting
  • Metastasis From Malignant Tumor of Prostate (Disorder)
  • 64Cu-PSMA I&T
  • New Haven, Connecticut
  • +7 more
Jan 17, 2023

High Grade Glioma Trial (177Lu-PSMA I&T)

Not yet recruiting
  • High Grade Glioma
  • 177Lu-PSMA I&T
  • (no location specified)
Dec 1, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Houston (Ac225-PSMA I&T)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Ac225-PSMA I&T
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jan 27, 2022

Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (99mTc-based PSMA Imaging and Surgery Agent, Computed

Recruiting
  • Prostate Carcinoma
  • Recurrent Prostate Carcinoma
  • 99mTc-based PSMA Imaging and Surgery Agent
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

Recruiting
  • Salivary Gland Cancer
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Oct 27, 2022

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • (no location specified)
Aug 8, 2023

Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • 225^Ac-PSMA-617
  • 68^Ga-PSMA-11
  • Darlinghurst, Australia
  • +1 more
Nov 23, 2022

Advanced and/or Metastatic Solid Tumours Trial in Groningen (Radiolabelled CB307, CB307)

Recruiting
  • Advanced and/or Metastatic Solid Tumours
  • Groningen, Netherlands
    University Medical Center Groningen,
Apr 28, 2023

Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)

Suspended
  • Castrate-Resistant Prostate Cancer
  • LIGHT-PSMA-CART cells
  • Shanghai, Shanghai, China
    Changhai Hospital
Jan 25, 2023

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,

Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • +3 more
  • Lutetium Lu-177 PNT2002
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022

Prostate Cancer Trial in Beijing (CART-PSMA cells)

Recruiting
  • Prostate Cancer
  • CART-PSMA cells
  • Beijing, China
    Chinese PLA General Hospital
Dec 12, 2022

Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)

Suspended
  • Biochemically Recurrent Prostate Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • Positron Emission Tomography
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Prostate Cancer Trial in Philadelphia (CART-PSMA-TGFßRDN cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Prostate Cancer
  • CART-PSMA-TGFβRDN cells
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 17, 2022

Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • (no location specified)
Dec 1, 2022

Prostate Cancer Trial in New Orleans, New York (177Lu-PSMA-617, 68Ga-PSMA-HBED-CC)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +1 more
Nov 20, 2021

Prostate Cancer Trial in Milan (99m-TC-PSMA-I&S)

Recruiting
  • Prostate Cancer
  • Milan, MI, Italy
    Ospedale San Raffaele
Aug 24, 2021

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

Active, not recruiting
  • Prostate Cancer
  • +5 more
  • 131I-PSMA-1095 Radioligand Therapy (RLT)
  • Montreal, Quebec, Canada
    Stephan Probst
Oct 24, 2022

Advanced Prostate Cancer Trial (HRS-4357 injection)

Not yet recruiting
  • Advanced Prostate Cancer
  • HRS-4357 injection
  • (no location specified)
Aug 16, 2023